In 2017, KDT became lead investor for INSIGHTEC, a commercial-stage medical device company revolutionizing surgery with incisionless, MRI-guided focused ultrasound—a technology with the potential to provide better treatment options to patients battling Parkinson’s, Alzheimer’s and multiple types of cancer.
